جست‌وجوی استاد و پژوهشگر

Joan M Eckersonمشاهده پروفایل

استاد

• Exercise Nutrition
• Dietary Supplements
• Exercise Performance
• +۵ مورد دیگر

Dr. Joan M Eckerson is a Professor in the Department of Exercise Science and Pre-Health Professions within Creighton University's College of Arts and Sciences. Her research program centers on the intersection of nutrition, exercise physiology, and human performance, with particular expertise in dietary supplements like creatine. She investigates their effects on athletic performance, body composition, immune function, and therapeutic applications in clinical populations. Her research interests span: Exercise Nutrition : Efficacy of ergogenic aids (creatine, pre-workout supplements) on athletic outcomes Clinical Applications : Mitigating chemotherapy-induced muscle wasting and cardiotoxicity using creatine/creatinine Physiological Assessment : Developing and validating performance tests (e.g., 3-min rowing test for VO2max estimation) Dietary Interventions : Impact of meal composition on satiety, nutrient intake, and metabolic health Gender-Specific Physiology : Nutritional needs and supplement responses in female athletes across the lifespan. Analysis of her recent publications reveals strong trends in exercise oncology and the immunomodulatory effects of creatine . Her work demonstrates increasing focus on clinical applications beyond athletic performance, particularly using creatine/creatinine to counteract doxorubicin toxicity in skeletal and cardiac muscle. Methodologically, she employs diverse techniques from cellular models (myoblasts) to athlete testing and dietary intervention studies. Dr. Eckerson maintains an active role in scientific dissemination, regularly presenting findings at major conferences including the American College of Sports Medicine (ACSM) and the National Strength and Conditioning Association (NSCA). She also engages in public science communication through radio appearances discussing dietary supplements.

Cica Vissiennonمشاهده پروفایل

استاد

• Medicinal Plants
• Pharmacology
• Ethnopharmacology
• +۶ مورد دیگر

Cica Vissiennon is a pharmacology researcher at the University of Leipzig , leading a research group since 2017. Her work bridges traditional African/European medicine with modern pharmacological methods, focusing on bioactivity testing of natural products for inflammatory diseases. Habilitation in pharmacology/toxicology (2023) Advisory Board Member, Society for Medicinal Plant and Natural Product Research Collaborated with European Medicines Agency and DAAD-funded projects Research Aims include: Elucidating mechanisms of natural substances in pathophysiological targets Developing in vitro models for drug testing Rationalizing traditional Western African healing approaches Recent article trends show focus on: Anti-inflammatory effects of Benin-derived plant extracts Synergistic interactions in herbal combinations Intestinal barrier stabilization using natural compounds Key Collaborations : University of Pretoria (2023 Summer School) IRGIB-Africa University (Benin) Makerere University (Uganda) Student Training : Mentored doctoral students in Leipzig Organized international research camps for young African scientists

Riitta Korpelaمشاهده پروفایل

استاد

• Biomedicine
• Nutrition
• Physiology
• +۴ مورد دیگر

Riitta Korpela is an Honorary Professor and Docent at the University of Helsinki's Faculty of Medicine (Medicum), actively supervising doctoral students across Clinical Research, Biomedicine, and Population Health programmes. With over 340 publications, her career bridges biomedicine, nutrition, and physiology to advance understanding of gastrointestinal disorders and nutritional interventions. Her research focuses on: Intestinal permeability mechanisms in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) Renin-angiotensin-aldosterone system (RAAS) dynamics within the gut mucosa Ketogenic diet effects on colitis and gut inflammation across diverse fat sources Probiotic interventions for respiratory/gastrointestinal infections eHealth solutions for obesity management integrating mental health outcomes Recent publications (2023-2025) demonstrate ketogenic diets' protective effects against experimental colitis independent of fat composition, alongside innovative eHealth trials improving weight metrics and psychological wellbeing in obese employees. Her work increasingly combines microbiome analysis with clinical biomarkers to personalize nutritional therapies. Dr. Korpela has supervised multiple doctoral theses including Minna Kumpu's work on grains/IBS and Laura Tapiovaara's research on antihypertensive tripeptides. She led the 2009-2012 project on probiotics for virus infections in military conscripts and maintains extensive national/international collaborations in nutrition science. Her research integrates mouse model studies with human clinical trials through University of Helsinki's Medicum infrastructure, emphasizing translational pathways from basic mechanisms to public health applications in gut health and obesity management.

Deepika Sharmaمشاهده پروفایل

استادیار

• Neuro-Immune Interactions
• Gut Mucosa Immunology
• Inflammation and Homeostasis
• +۲ مورد دیگر

Deepika Sharma, PhD, is an Assistant Professor in the Department of Microbiology and Immunology at the University of North Carolina at Chapel Hill. She is a member of the UNC Lineberger Comprehensive Cancer Center and focuses on neuro-immune interactions in inflammation and homeostasis, particularly in the gut mucosa. Her research explores how sympathetic neurons influence colon tumorigenesis and stress-related disease exacerbation. University: University of North Carolina at Chapel Hill School: UNC School of Medicine Department: Microbiology and Immunology Academic Rank: Assistant Professor Research Interests: Dr. Sharma investigates neuro-immune modules governing tissue immunity, emphasizing their role in inflammation and homeostasis. Her work bridges basic research with translational outcomes to address intestinal and systemic immune disorders. Awards and Honors: Invited speaker, 'Future Leaders of Immunology Symposium' (2023) Milstein Trainee Award (2018, 2022) GIRF Associates Broad Award (2018) Fellowships from Michigan State University (2013, 2014) Education: PhD in Immunology from Michigan State University (2013).

Terrence Fureyمشاهده پروفایل

استاد

• Epigenetics
• Gene Regulation
• Inflammatory Bowel Diseases (IBD)
• +۴ مورد دیگر

Dr. Terrence (Terry) Furey is a Professor in the Department of Genetics and Biology at the UNC School of Medicine. His research focuses on gene regulatory processes, particularly epigenetically controlled mechanisms, and their role in complex diseases like inflammatory bowel diseases (IBD). The Furey Lab specializes in computational analysis of genome-wide open chromatin, histone modifications, miRNA, and gene transcription data from high-throughput sequencing experiments. Key research areas: Epigenetics, Chromatin Biology, IBD Pathogenesis, Computational Genomics, Microbiome Interactions Specialized methodologies: Development of statistical and computational tools for genomic data analysis Research highlights include investigating genetic and epigenetic contributors to IBD through collaborations with Dr. Shehzad Sheikh, particularly analyzing chromatin reprogramming, miRNA expression, and microbial composition in both IL-10 knockout models and human intestinal tissues. The lab has identified distinct molecular signatures of Crohn's disease associated with clinical phenotypes. Article trends demonstrate expertise spanning Chromatin accessibility analysis in disease states MicroRNA biomarker discovery in IBD Computational tool development (ROCCO, DeFCoM, GSAASeqSP) Multi-omics integration in complex phenotypes Environmental-genetic interaction studies Translational IBD research Dr. Furey actively collaborates with researchers across the Center for Gastrointestinal Biology and Disease (CGIBD), including Drs. Sartor, Sheikh, and Rusyn. His work bridges clinical/translational research with microbiome studies , focusing on how epigenetic landscape alterations contribute to disease progression.

Amanda Zieglerمشاهده پروفایل

استادیار

• Gastroenterology
• Intestinal Barrier Repair
• Enteric Nervous System
• +۴ مورد دیگر

Amanda Ziegler, DVM, PhD is an Assistant Research Professor in the Department of Clinical Sciences at North Carolina State University. She leads the Comparative Gastroenterology Lab, focusing on intestinal barrier repair mechanisms, particularly in neonatal and juvenile large animal models. Her work bridges veterinary medicine, gastroenterology, and developmental biology to understand intestinal wound healing processes. Dr. Ziegler's primary research interests center on gastrointestinal biology and disease, with specific focus on: Intestinal barrier repair and restitution mechanisms Enteric nervous system development and function Neonatal intestinal development and repair Large animal models (particularly porcine) for translational research Comparative gastroenterology across species Intestinal wound healing following ischemic injury Her recent publications demonstrate a strong emphasis on molecular mechanisms of intestinal repair, particularly examining the role of enteric glial cells in regulating epithelial restitution. She has pioneered the use of single-cell transcriptomics to compare pig and human epithelial phenotypes, identifying a "restitution/hybrid EMT phenotype." Her work increasingly incorporates microbiome research, prebiotic interventions, and comparative approaches across species to understand fundamental mechanisms of intestinal healing. Dr. Ziegler has received notable recognition including a K01 award and the CGIBD Pilot and Feasibility Award in 2018. Her research has been supported by grants focused on understanding intestinal barrier repair in early life. As principal investigator of the Comparative Gastroenterology Lab, Dr. Ziegler leads research investigating how the developing enteric glial cell network regulates intestinal barrier repair in postnatal life. Her lab employs innovative large animal models to study intestinal wound healing with translational applications for neonatal care in both veterinary and human medicine.

Jonathan A. Fridellمشاهده پروفایل

استاد

• Pancreas Transplantation
• Liver Transplantation
• Diabetes Management
• +۳ مورد دیگر

Dr. Jonathan A. Fridell is a Professor of Surgery at Indiana University School of Medicine and Chief of Abdominal Transplant Surgery at IU Health. He joined IU in 2002 and has since expanded the pancreas and multivisceral transplant programs into national leaders. His clinical practice specializes in pancreas transplantation for Type 1 and Type 2 diabetes patients with hypoglycemic unawareness. His research spans: Pancreas & liver transplantation : Innovations in surgical techniques and outcomes optimization. Diabetes management : Addressing hypoglycemic unawareness through advanced transplants. Multivisceral transplants : Pioneering intestine/multiorgan procedures. He publishes extensively on transplant efficacy, organ allocation ethics, and clinical guidelines. Leadership roles include: Councilor, International Pancreas & Islet Transplant Association (IPITA) Board Member, Indiana Donor Network Former Chair, UNOS Pancreas Transplant Committee Honors: IU Health President’s Values Leadership Award (2020) Education: MD & Surgical Training: McGill University Fellowship: University of Pittsburgh Starzl Transplant Institute

• HIV/SIV Pathogenesis
• Gut-Immune Axis
• Infectious Diseases
• +۷ مورد دیگر

Dr. Ivona Pandrea is a Professor of Pathology in the Division of Experimental Pathology at the University of Pittsburgh School of Medicine and a member of the Cellular and Molecular Pathology Graduate Training Program. Board certified in Pathology since 1997, she specializes in Pathology, Immunology, and Virology with a research focus on HIV/SIV pathogenesis. Dr. Pandrea received her MD (1992) and PhD (1999) from Grigore T. Popa School of Medicine and Pharmacy in Iași, Romania. Her research has been recognized with numerous awards including the Tempus Fellowship, multiple Tulane University research awards, and the TUHSC Auxiliary Research Career Development Award. Her laboratory pioneered HIV research in African nonhuman primates to establish mechanisms responsible for lack of disease progression in these species. Current research focuses on intestinal dysfunction in infectious diseases, particularly examining how SIV/HIV and SARS-CoV-2 infections impact gut health and cause systemic changes through microbial translocation, metabolite alterations, and inflammation. The lab also studies immunometabolic axes between the gut and other organ systems, the role of gut dysfunction in accelerating aging in HIV, and the impact of behavioral factors like diet and alcohol on disease progression. Dr. Pandrea's publication record shows consistent output in high-impact journals, with recent work emphasizing gut microbiome changes, cardiovascular comorbidities in HIV, and novel nonhuman primate models. Her research has evolved from basic SIV pathogenesis to therapeutic interventions targeting chronic inflammation. Awardee of prestigious fellowships and research grants, Dr. Pandrea's scientific contributions include: Tempus Fellowship (1995-1996) Association pour la Recherche contre le Cancer Fellowship (1996-1998) NIH Young Scientist Travel Grant (2002) IAS Conference International Award (2003) Tulane University Promise and Leadership in Research Awards (2005) TUHSC Auxiliary Research Career Development Award (2006) Dr. Pandrea maintains an active research program with NIH funding, developing numerous nonhuman primate models for AIDS research, inflammatory bowel diseases, and myocardial infarction. Her lab investigates dietary and pharmaceutical interventions to reduce chronic inflammation in people living with HIV, with recent work focusing on adenosine pathways and NETosis inhibition. The Pandrea Research Lab is located at the University of Pittsburgh with laboratory facilities focused on nonhuman primate studies, gut immunology, and microbiome analysis. The lab maintains collaborations with multiple institutions for specialized analyses including microbiome sequencing, metabolomics, and imaging studies.

Luce Landraudمشاهده پروفایل

دانشیار

• Microbiology
• Antibiotic Resistance
• Bacterial Virulence
• +۳ مورد دیگر

Luce Landraud is an Associate Professor (MCU-PH) and permanent researcher at University of Paris, Faculty of Medicine, affiliated with IAME INSERM U1137. She serves as a core investigator in the EVREST team, which addresses antibiotic resistance and virulence evolution in bacterial pathogens through ecological and evolutionary frameworks. Her academic credentials include: PhD in Bacteriology, Medical School, Nice Sophia Antipolis (2004-2015) PhD in Microbiology, Medical School, Paris Sorbonne Cité (2015-present) Dr. Landraud's research centers on antibiotic resistance dynamics in Enterobacterales , with emphasis on plasmid fitness costs , virulence-resistance coevolution , and E. coli pathogenomics. She integrates genomic surveillance, experimental evolution, and clinical data to investigate how resistance mechanisms emerge and persist in bacterial populations across healthcare and environmental settings. Analysis of her 2020-2023 publications reveals consistent focus on genomic epidemiology of resistance plasmids, iron-mediated virulence pathways, and therapeutic alternatives like phage therapy. Key contributions appear in high-impact venues including Nature Communications and Antimicrobial Agents and Chemotherapy, demonstrating methodological innovation in resistance tracking and evolutionary modeling. No specific scientific awards were documented in available sources. Dr. Landraud actively supervises research within the EVREST framework and participates in multicenter clinical trials. Her work receives support from INSERM and national research agencies, enabling large-scale genomic studies and translational projects addressing urgent antibiotic resistance challenges. As an EVREST team member, she contributes to three research axes: (1) virulence/resistance evolution, (2) antibiotic response in microbial communities, and (3) therapeutic repurposing. The team employs advanced genomic, microbiological, and computational approaches to investigate resistance mechanisms in clinical isolates and experimental models.

Michael Frommمشاهده پروفایل

استاد

• Intestinal barrier physiology
• Tight junction proteins
• Claudin family
• +۵ مورد دیگر

Professor Michael Fromm is a Senior Professor of Clinical Physiology / Nutritional Medicine at Charité – Universitätsmedizin Berlin, where he has been affiliated since the 1970s. His primary appointment is within the Medical Clinic for Gastroenterology, Infectious Diseases and Rheumatology, specifically in the Division of Clinical Physiology / Nutritional Medicine at Campus Benjamin Franklin. His research focuses on the permeability of the intestinal wall in inflammatory diseases, with particular emphasis on tight junction proteins including claudins and tricellulin. Professor Fromm's work has established him as a leading authority on epithelial barrier function, with significant contributions to understanding how tight junction proteins regulate paracellular transport of ions, water, and macromolecules. His research has important implications for inflammatory bowel diseases like Crohn's disease and ulcerative colitis, and has consistently appeared in high-impact journals across cell biology, physiology, and gastroenterology. His recent publications demonstrate continued leadership in the field, with numerous papers on claudin function, tricellular tight junctions, and their roles in disease pathogenesis and potential therapeutic applications. Professor Fromm has secured substantial research funding, including multiple grants from the German Research Foundation (DFG), where he has served as a liaison officer for Charité since 2008. He has held significant leadership positions including Director of the Institute of Clinical Physiology (2002-2014), Chair of the Benjamin Franklin Medical School research committee (1993-2003), and Secretary General of the European Intestinal Transport Group (1998-2015). Currently, he serves on the Ethics Committee of Charité and is Editor-in-Chief for the Physiology section of Biology (Basel).

• Lipidomics
• Metabolomics
• Inflammatory Bowel Disease (IBD)
• +۷ مورد دیگر

Lorena Ortega Moreno is an Assistant Professor in the Basic Health Sciences Department at King Juan Carlos University (URJC), Madrid, Spain. Her research focuses on the intersection of lipidomics, metabolomics, and inflammatory bowel disease (IBD) pathogenesis, with particular emphasis on biomarker discovery and gut-brain axis mechanisms. She leads the IMPULSO-URJC project investigating extracellular vesicles in colorectal cancer. Her research interests span: Lipidomics and metabolomics for biomarker discovery in gastrointestinal disorders Adipokine biology in inflammatory and metabolic diseases Long non-coding RNA roles in IBD pathogenesis and treatment response Extracellular vesicle characterization in colorectal cancer Gut-brain axis interactions in neurodegenerative conditions Her work integrates multi-omics approaches to identify non-invasive diagnostic tools and therapeutic targets for IBD and related conditions. Analysis of her 15 most recent publications reveals consistent focus on: IBD biomarker discovery through lncRNA, proteomic, and metabolomic profiling Translational applications of microbiome-derived compounds Metabolite signatures for disease stratification (COVID-19, diabetes complications) Cross-disease applications of lipidomics in neurodegeneration Her methodology emphasizes clinical validation of omics findings for diagnostic applications. Scientific recognition includes: Two Research Quinquennia (Sexenios de Investigación) awarded by ANECA in 2023 Extensive international collaboration network across Europe and US institutions Her advisory and grant portfolio demonstrates strong leadership in translational research: Principal Investigator for IMPULSO-URJC project on extracellular vesicles in colorectal cancer (2025) Recipient of Comunidad de Madrid Talent Attraction Grant (2018-2022) Previous Hearst Foundation postdoctoral fellowship at Joslin Diabetes Center She maintains active collaborations with Hospital Universitario La Princesa and international research groups. Her laboratory work centers on the Gut Immunology Research Lab, utilizing: Multi-omics platforms (lipidomics, metabolomics, proteomics) Extracellular vesicle isolation and characterization Translational animal models for gut-brain axis studies Clinical sample analysis from IBD and colorectal cancer cohorts Current efforts focus on developing non-invasive diagnostic tools for gastrointestinal disorders.

Andrew Smithمشاهده پروفایل

استاد

• Immunology
• Oral Medicine
• Microbiology
• +۵ مورد دیگر

Professor Andrew Smith is Chair in Oral Health Sciences at University College London's Eastman Dental Institute, where he leads research connecting oral health with systemic inflammatory conditions. His work bridges dental and medical fields, particularly investigating Crohn's disease, ulcerative colitis, and oral manifestations of inflammatory conditions through advanced laboratory and clinical approaches. Education: PhD, University of Southampton (1998) BSc (Hons), University of Leeds (1995) Smith's research program focuses on three interconnected areas: macrophage immune responses, epithelial integrity in mucosal inflammation, and microbiome influences on inflammatory diseases. His laboratory employs genetic analysis, transcriptomic profiling, in vivo and in vitro disease modeling, and proteomics to investigate cytokine secretion mechanisms and their role in disease pathogenesis. His team has demonstrated that the oral microbiome is primarily shaped by environmental factors rather than genetics, with implications for both oral and gastrointestinal health management. His recent publications reveal increasing emphasis on organoid technology, microbiome analysis, and novel drug delivery systems for mucosal diseases. The research shows strong translational focus, connecting basic immunological mechanisms with clinical observations in patient populations. His work on the relationship between biologic therapies for Crohn's disease and oral health outcomes has provided important insights into the oral-systemic disease connection. Research Contributions: Established 20-year clinical-scientific collaboration with Dr. Farooq Rahman Developed patient-derived organoid models for inflammatory disease research Demonstrated environmental dominance in shaping oral microbiome Investigated connections between TNF inhibitors and periodontal health Advanced understanding of cytokine trafficking in immune cells Professor Smith supervises multiple PhD students and postdoctoral researchers while collaborating with clinicians at University College Hospital and Royal Free Hospital. His international research team includes scientists, clinicians, dentists, and nutritionists working across disciplines to unravel complex immune-microbiome interactions in inflammatory diseases. The Smith-Rahman research group maintains sophisticated facilities for patient-derived organoid culture, microbiome profiling, and advanced imaging including microCT for dental and bone analysis, supporting their integrated approach to inflammatory disease research.

Erin Steinbachمشاهده پروفایل

استادیار

• Food Allergy
• Peanut Allergy
• Eosinophilic Gastrointestinal Disease
• +۵ مورد دیگر

Erin Steinbach, MD, PhD is an Assistant Professor of Medicine at the UNC School of Medicine, University of North Carolina at Chapel Hill. Specializing in food allergy , peanut allergy , and gastrointestinal immunology , her research explores mechanisms of allergen immunotherapy , microbiota-host interactions , and epithelial barrier dysfunction in allergic diseases. Education: Bachelor of Science, Gustavus Adolphus College MD and PhD, University of North Carolina at Chapel Hill Residency & Fellowship, University of North Carolina Hospitals Her research integrates immunology and gastroenterology , focusing on microbiota regulation of intestinal inflammation , food antigen sensitization , and epithelial barrier integrity . Recent publications in Frontiers in Immunology and Clinical & Experimental Allergy highlight her work on BET protein inhibition , ACE2 expression , and angiopoietin-like 4 in allergic pathologies.

Benjamin Anderschou Holbech Jensenمشاهده پروفایل

دانشیار

• Nutritional Immunology
• Compartmentalized Immunology
• Host Defence Peptides
• +۷ مورد دیگر

Benjamin A. H. Jensen is a tenured Associate Professor in Nutritional Immunology at the Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen. He leads the Jensen Group which focuses on barrier (dys)function and investigates how dietary components, gut microbial community structures, and compartmentalized immunology interact to orchestrate chronic inflammation. His research has been published in top-tier journals including Nature, Nature Metabolism, Cell Metabolism, and GUT. Dr. Jensen earned his PhD in Molecular Biomedicine from the University of Copenhagen in 2016, with a thesis titled "Insulin Resistance: A Fine-Tuned Interplay Between Diet, Intestinal Microbes and Immunity." Prior to this, he completed an MSc in Biochemistry with a major in Immunology (2013) and a Diploma of Engineering in Biotechnology (2012). His research interests center on nutritional immunology, particularly host defense peptides (HDPs) and their influence on host-microbe mutualism in chronic inflammatory diseases. The Jensen Group develops experimental systems tailored to model human diseases with unmet medical needs, with a specific focus on the gut-liver, gut-lung, and gut-brain axes. His work emphasizes sound and reproducible research over high-impact publications, aiming to make discoveries that benefit society. His recent publications demonstrate a strong focus on the interactions between diet, gut microbiome, and host immunity in metabolic diseases like obesity and type 2 diabetes. The research spans from basic molecular mechanisms to translational applications, with particular attention to how dietary components and host defense peptides influence disease progression and potential treatments. Emerging Excellence Investigator award, Novo Nordisk Foundation (2021) Nominated for 'Scientific Discovery of the Year' by Québec Science, Canada (2021) Featured as #BestofNatMetab2020 in Nature Metabolism (2021) Featured on the frontpage of Nature Metabolism (2020) Scientific advisor to the International Life Sciences Institute (ILSI), Europe, Probiotic Task Force (2022) Dr. Jensen serves as main supervisor for 3 postdocs (1 industrial), 1 PhD student (with 3 additional as co-supervisor), and numerous master's and bachelor's students. He has co-invented two issued patents and founded Aesculus Bio ApS. His group collaborates with academic and industrial partners across multiple countries, reflecting his international research network. He has received significant grant funding including the prestigious Novo Nordisk Foundation Excellence Emerging Investigator Grant (2021) to establish his research group. The Jensen Group operates at the intersection of nutritional science, immunology, and microbiome research, with a strong translational focus on developing novel approaches for chronic inflammatory diseases. Their work combines advanced experimental models with clinical insights to bridge the gap between basic science and therapeutic applications.

• Endocrinology
• Metabolism
• Gut Hormone Biology
• +۳ مورد دیگر

Hannelouise Kissow serves as Associate Professor in the Department of Biomedical Sciences at the University of Copenhagen's Faculty of Health and Medical Sciences, specializing in endocrinology and metabolism with emphasis on gut hormone pathways and intestinal disease mechanisms. Her academic credentials include: PhD from University of Copenhagen (2012) Medical Doctor degree (2006) Authorization for independent medical practice (2008) Research centers on gut hormone biology, particularly incretin systems (GLP-1/GLP-2), short-chain fatty acids, and nutraceutical interventions for colitis and metabolic disorders. Her work bridges preclinical mouse models with clinical trials, examining intestinal adaptation in short bowel syndrome and hormonal predictors of weight loss maintenance. Current projects include Lundbeck-funded research on dietary fiber as intestinal disease prophylaxis. Recent publications (2023-2025) reveal dominant themes in incretin physiology, intestinal barrier function, and clinical translation of peptide therapeutics. Key methodological approaches span molecular receptor studies, translational animal models, and randomized controlled trials in gastrointestinal and metabolic diseases. Academic service includes editorial roles as Associate Editor for Frontiers in Endocrinology (Gut Endocrinology section) and Guest Editor for Biomedicines, alongside peer review for major endocrinology and nutrition journals. She supervises three PhD candidates, three master's students, and ten bachelor's students while leading anatomy instruction for 5th-semester medical students. Research funding includes principal investigator roles for projects like "Dietary fiber as a nutraceutical to protect against intestinal diseases" (Lundbeck Foundation). As head of the Gut Hormone Biology group since 2013, she maintains active collaborations within the NNF Center for Basic Metabolic Research and international networks evidenced by multi-country co-authorship in recent publications.